News Headlines Article

FDA moves to revoke Avastin’s approval for breast cancer
Washington Post

Federal regulators took the unusual step Thursday of moving to revoke approval of a drug that women with advanced breast cancer turn to in a last-ditch effort to save their lives. The decision intensifies a politically charged debate over costly cancer drugs that appear to produce modest benefits – if any.